Am J Psychiatry 156:1417-1420, September 1999
© 1999 American Psychiatric Association
Elevated Frequency of Diabetes Mellitus in Hospitalized Manic-Depressive Patients
Frederick Cassidy, M.D.,
Eileen Ahearn, M.D., Ph.D., and
J. Carroll, M.B., Ph.D.
OBJECTIVE: Disturbance in glucose homeostasis in psychiatric populations has been suggested since the early part of this century. Increased comorbidity of diabetes mellitus in persons with major mood disorders has also been suggested. The goal of this study was to determine whether subjects diagnosed with bipolar disorder have an elevated rate of comorbid diabetes mellitus. METHOD: Three hundred forty-five hospitalized patients, aged 20–74 years, who met the DSM-III-R criteria for bipolar disorder, manic or mixed subtype, were evaluated for a comorbid diagnosis of diabetes mellitus. The frequency of diabetes mellitus in the study group was determined and compared with the expected frequency, calculated as a weighted average based on sex and age from national norms. Variables characterizing the course and severity of the affective disorder in the group of diabetic bipolar subjects and a group of nondiabetic age-matched bipolar subjects were compared. RESULTS: The prevalence of diabetes mellitus among these bipolar patients was 9.9%, significantly greater than expected from national norms (3.4%). The patients with comorbid diabetes mellitus had significantly more lifetime psychiatric hospitalizations than the nondiabetic subjects, but age at first hospitalization and duration of psychiatric disorder were similar in the two groups. CONCLUSIONS: The frequency of diabetes mellitus in hospitalized patients diagnosed with bipolar disorder is higher than in the general population. Manic-depressive patients with diabetes mellitus have a more severe course of illness, as indicated by a greater number of psychiatric hospitalizations. Possible reasons for this increased comorbidity include a genetic relationship between the disorders, a causal relationship in which hypercortisolemia induces diabetes or diabetic vascular lesions contribute to mania, an overlapping functional disturbance affecting similar regions of the brain, or the effect of psychotropic medications.
This article has been cited by other articles:
|
|
|
|
 
J. G. Fiedorowicz, D. A. Solomon, J. Endicott, A. C. Leon, C. Li, J. P. Rice, and W. H. Coryell
Manic/Hypomanic Symptom Burden and Cardiovascular Mortality in Bipolar Disorder
Psychosom Med,
July 1, 2009;
71(6):
598 - 606.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Kilbourne, E. P. Post, A. Nossek, L. Drill, S. Cooley, and M. S. Bauer
Improving Medical and Psychiatric Outcomes Among Individuals With Bipolar Disorder: A Randomized Controlled Trial
Psychiatr Serv,
July 1, 2008;
59(7):
760 - 768.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. K. Varma, K. Connolly, and B. Fulton
Life-Threatening Hyperglycemia and Acidosis Related to Olanzapine: A Case Report and Review of the Literature
J Intensive Care Med,
January 1, 2007;
22(1):
52 - 55.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. P. Carney and L. E. Jones
Medical comorbidity in women and men with bipolar disorders: a population-based controlled study.
Psychosom Med,
September 1, 2006;
68(5):
684 - 691.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Morriss and F. A. Mohammed
Metabolism, lifestyle and bipolar affective disorder
J Psychopharmacol,
November 1, 2005;
19(6_suppl):
94 - 101.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. M. Gardner, R. J. Baldessarini, and P. Waraich
Modern antipsychotic drugs: a critical overview
Can. Med. Assoc. J.,
June 21, 2005;
172(13):
1703 - 1711.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. R. R. Krishnan
Psychiatric and Medical Comorbidities of Bipolar Disorder
Psychosom Med,
January 1, 2005;
67(1):
1 - 8.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. TAYLOR, C. YOUNG, R. ESOP, C. PATON, and R. WALWYN
Testing for diabetes in hospitalised patients prescribed antipsychotic drugs
The British Journal of Psychiatry,
August 1, 2004;
185(2):
152 - 156.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Vreeland and E. Kim
Managing the Clinical Consequences of Psychiatric Illness and Antipsychotic Treatment: A Discussion of Obesity, Diabetes, and Hyperprolactinemia
Journal of the American Psychiatric Nurses Association,
June 1, 2004;
10(3_suppl):
S17 - S24.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. Bushe and R. Holt
Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia
The British Journal of Psychiatry,
April 1, 2004;
184(47):
s67 - s71.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Rasgon and L. Jarvik
Insulin Resistance, Affective Disorders, and Alzheimer's Disease: Review and Hypothesis
J. Gerontol. A Biol. Sci. Med. Sci.,
February 1, 2004;
59(2):
M178 - 183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. G. Lyketsos, G. Dunn, M. J. Kaminsky, and W. R. Breakey
Medical Comorbidity in Psychiatric Inpatients: Relation to Clinical Outcomes and Hospital Length of Stay
Psychosomatics,
February 1, 2002;
43(1):
24 - 30.
[Abstract]
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1999
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
